173 related articles for article (PubMed ID: 36628830)
21. Vesicostomy for neurogenic bladder with spina bifida: followup.
Snyder HM; Kalichman MA; Charney E; Duckett JW
J Urol; 1983 Oct; 130(4):724-6. PubMed ID: 6350621
[TBL] [Abstract][Full Text] [Related]
22. The timing of primary neurosurgical repair significantly affects neurogenic bladder prognosis in children with myelomeningocele.
Tarcan T; Onol FF; Ilker Y; Alpay H; Simşek F; Ozek M
J Urol; 2006 Sep; 176(3):1161-5. PubMed ID: 16890717
[TBL] [Abstract][Full Text] [Related]
23. Urological evaluation of patients that had undergone in utero myelomeningocele closure: A prospective assessment at first presentation and early follow-up. Do their bladder benefit from it?
Macedo A; Leal M; Rondon A; Ortiz V; Moron AF; Cavalheiro S
Neurourol Urodyn; 2015 Jun; 34(5):461-4. PubMed ID: 24729268
[TBL] [Abstract][Full Text] [Related]
24. Rate of shunt revision as a function of age in patients with shunted hydrocephalus due to myelomeningocele.
Dupepe EB; Hopson B; Johnston JM; Rozzelle CJ; Jerry Oakes W; Blount JP; Rocque BG
Neurosurg Focus; 2016 Nov; 41(5):E6. PubMed ID: 27798984
[TBL] [Abstract][Full Text] [Related]
25. Prenatal myelomeningocele repair: Do bladders better?
Horst M; Mazzone L; Schraner T; Bodmer C; Möhrlen U; Meuli M; Gobet R
Neurourol Urodyn; 2017 Aug; 36(6):1651-1658. PubMed ID: 27862250
[TBL] [Abstract][Full Text] [Related]
26. Characteristics and survival of patients with end stage renal disease and spina bifida in the United States renal data system.
Ouyang L; Bolen J; Valdez R; Joseph D; Baum MA; Thibadeau J
J Urol; 2015 Feb; 193(2):558-64. PubMed ID: 25167993
[TBL] [Abstract][Full Text] [Related]
27. Botulinum injection is useless on fibrotic neuropathic bladders.
Tiryaki S; Yagmur I; Parlar Y; Ozel K; Akyildiz C; Avanoglu A; Ulman I
J Pediatr Urol; 2015 Feb; 11(1):27.e1-4. PubMed ID: 25448589
[TBL] [Abstract][Full Text] [Related]
28. Mortality after bladder augmentation in children with spina bifida.
Szymanski KM; Misseri R; Whittam B; Adams CM; Kirkegaard J; King S; Kaefer M; Rink RC; Cain MP
J Urol; 2015 Feb; 193(2):643-8. PubMed ID: 25072178
[TBL] [Abstract][Full Text] [Related]
29. Long-term urological impact of fetal myelomeningocele closure.
Clayton DB; Tanaka ST; Trusler L; Thomas JC; Pope JC; Adams MC; Brock JW
J Urol; 2011 Oct; 186(4 Suppl):1581-5. PubMed ID: 21862080
[TBL] [Abstract][Full Text] [Related]
30. In utero myelomeningocele repair and incidence of lower urinary tract surgery. Results of a prospective study.
Macedo A; Ottoni SL; Garrone G; Moron A; Cavalheiro S; Leal da Cruz M
J Pediatr Urol; 2021 Dec; 17(6):769-774. PubMed ID: 34452829
[TBL] [Abstract][Full Text] [Related]
31. Effect of Prenatal Repair of Myelomeningocele on Urological Outcomes at School Age.
Brock JW; Thomas JC; Baskin LS; Zderic SA; Thom EA; Burrows PK; Lee H; Houtrow AJ; MacPherson C; Adzick NS;
J Urol; 2019 Oct; 202(4):812-818. PubMed ID: 31075056
[TBL] [Abstract][Full Text] [Related]
32. Radiographic abnormalities, bladder interventions, and bladder surgery in the first decade of life in children with spina bifida.
Rensing AJ; Szymanski KM; Misseri R; Roth JD; King S; Chan K; Whittam BM; Kaefer M; Rink RC; Cain MP
Pediatr Nephrol; 2019 Jul; 34(7):1277-1282. PubMed ID: 30826869
[TBL] [Abstract][Full Text] [Related]
33. Differences in urodynamic study variables in adult patients with neurogenic bladder and myelomeningocele before and after augmentation enterocystoplasty.
Vainrib M; Reyblat P; Ginsberg DA
Neurourol Urodyn; 2013 Mar; 32(3):250-3. PubMed ID: 22965686
[TBL] [Abstract][Full Text] [Related]
34. Onabotulinumtoxin A for treating overactive/poor compliant bladders in children and adolescents with neurogenic bladder secondary to myelomeningocele.
Marte A
Toxins (Basel); 2012 Dec; 5(1):16-24. PubMed ID: 23274271
[TBL] [Abstract][Full Text] [Related]
35. Urodynamic characteristics of neurogenic bladder in newborns with myelomeningocele and refinement of the definition of bladder hostility: Findings from the UMPIRE multi-center study.
Tanaka ST; Yerkes EB; Routh JC; Tu DD; Austin JC; Wiener JS; Vasquez E; Joseph DB; Ahn JJ; Wallis MC; Williams T; Rose C; Baum MA; Cheng EY
J Pediatr Urol; 2021 Oct; 17(5):726-732. PubMed ID: 34011486
[TBL] [Abstract][Full Text] [Related]
36. Implications of Bacteriuria in Myelomeningocele Patients at Time of Urodynamic Testing.
Preece J; Haynes A; Gupta S; Becknell B; Ching C
Top Spinal Cord Inj Rehabil; 2019; 25(3):241-247. PubMed ID: 31548791
[No Abstract] [Full Text] [Related]
37. [Efficacy of toxin-A Botulinum for treating intractable bladder hyperactivity in children affected by neuropathic bladder secondary to myelomeningocele: an alternative to enterocystoplasty].
Marte A; Vessella A; Cautiero P; Romano M; Borrelli M; Noviello C; Del Gado R; Parmeggiani P
Minerva Pediatr; 2005 Feb; 57(1):35-40. PubMed ID: 15791200
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous vesicostomy revisited--the second 15 years.
Vastyan AM; Pinter AB; Farkas A; Vajda P; Somogyi R; Juhasz Z
Eur J Pediatr Surg; 2005 Jun; 15(3):170-4. PubMed ID: 15999309
[TBL] [Abstract][Full Text] [Related]
39. Urological consequences of incomplete cord lesions in patients with myelomeningocele.
Keshtgar AS; Rickwood AM
Br J Urol; 1998 Aug; 82(2):258-60. PubMed ID: 9722763
[TBL] [Abstract][Full Text] [Related]
40. Total endoscopic management (TEM approach) of children with non-compliant neuropathic bladder: a preliminary report.
Neel KF; Salem M; Soliman S
J Pediatr Urol; 2008 Apr; 4(2):124-6. PubMed ID: 18631907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
